Neurogene Inc
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurogene Inc and other ETFs, options, and stocks.About NGNE
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
NGNE Key Statistics
Stock Snapshot
With a market cap of 283M, Neurogene Inc(NGNE) trades at $18.31. The stock has a price-to-earnings ratio of -4.14.
On 2026-01-24, Neurogene Inc(NGNE) stock traded between a low of $18.12 and a high of $19.21. Shares are currently priced at $18.31, which is +1.0% above the low and -4.7% below the high.
Neurogene Inc(NGNE) shares are trading with a volume of 78.27K, against a daily average of 118.25K.
During the past year, Neurogene Inc(NGNE) stock moved between $6.88 at its lowest and $37.27 at its peak.
During the past year, Neurogene Inc(NGNE) stock moved between $6.88 at its lowest and $37.27 at its peak.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.